T he timely assessment of the extent of jeopardized myocardium, the success or failure of thrombolysis, and the degree of myocardial salvage is of major clinical importance in patients with acute myocardial infarction. In a patient with chest pain thought to be ischemic in origin, it would be useful to know immediately whether the coronary artery is occluded and the extent of the risk area, since this information Villanueva et al MCE Defines Risk Area and Infarct Size 597 exclusively in irreversibly injured myocardium-58 and occur in proportion to the extent and severity of cellular necrosis. 6, 7 Because reduced blood flow and impaired microvascular flow reserve are hallmarks of myocardial necrosis during reperfusion, we hypothesized that an intravascular tracer of blood flow can be used not only to define risk area during coronary occlusion but also to determine infarct size after reperfusion. We tested this hypothesis using myocardial contrast echocardiography (MCE), which uses air-filled microbubbles that have an intravascular rheology similar to that of red blood cells.9,10 Abnormalities in microvascular reserve were elicited by use of pharmacologically induced hyperemia with intravenous infusion of either dipyridamole or dobutamine. We have previously demonstrated that these agents also enhance the ability to produce myocardial opacification from right atrial (RA) injection of contrast."1 Methods
Animal Preparation
A canine model of 3 to 6 hours of coronary occlusion followed by 15 minutes of reperfusion was used. The protocol conformed to guidelines for animal research use at the University of Virginia. One dog with left atrial (LA) injection of contrast alone, nine with RA injection alone, and eight with both RA and LA injection were studied. All LA injections resulted in myocardial opacification. Since myocardial opacification from RA injection is not always successful,11 only dogs with successful opacification from RA injection of contrast at baseline were subjected to the entire protocol. The 17 dogs subjected to RA injection of contrast received either an intravenous infusion of 15 gg -kg`* min1-of dobutamine (Eli Lilly Corp, Indianapolis, Ind) (n=11) or 0.56 mg/kg of dipyridamole (Dupont Medical Products, Wilmington, Del) administered over a period of 4 minutes (n=6). Of these, 6 dogs receiving dobutamine (55%) and 5 receiving dipyridamole (84%) had successful myocardial opacification at baseline; only data from these dogs are presented here. These success rates for myocardial opacification from RA injections of contrast with these two pharmacological agents at these doses are consistent with our previous observations.11
The dogs were anesthetized with 30 mg/kg sodium pentobarbital (Abbott Laboratories, North Chicago, Ill), intubated, and ventilated with a respirator pump (model 607, Harvard Apparatus, Natick, Mass). Additional anesthesia was administered during the experiment as needed. A 7F catheter was placed in the right femoral artery for recording of arterial pressure and withdrawal of reference samples for radiolabeled microsphere analysis. This catheter was connected to a multichannel recorder ( 
Left Atrial Injections
In one of the nine dogs receiving LA injection of contrast, data were not analyzed because of suboptimal quality of the images produced by entrapment of air between the saline bath and the anterior surface of the heart. Fig Results from the 11 dogs with successful myocardial opacification at all stages during RA injections of contrast are depicted in Fig 5. Risk area size ranged from 18% to 49%, and infarct size varied from 0% to 23% of the myocardial short-axis slice. There was a close linear relation between autoradiography and MCE-derived measurements of risk area (panel A). Similarly, the size of the residual contrast defect during reperfusion closely approximated TTC-determined infarct size (panel B). As in the dogs with LA injections, the size of the perfusion defect after reflow was always smaller than during coronary occlusion.
Myocardial Blood Flow
Radiolabeled microsphere-derived myocardial blood flow was measured in 11 dogs during reperfusion. There was a significant inverse relation between the size of the residual defect on MCE during reperfusion, expressed as percentage of the risk area, and blood flow to the risk area, expressed as percentage of flow to the normal bed (Fig 6,  A) . These results imply that contrast defects noted on MCE during reperfusion in the presence of pharmacologically induced hyperemia indicate regions with relatively reduced blood flow, impaired microvascular flow reserve, or both. When the ratios of background-subtracted peak video intensities from the endocardium and epicardium of the occluded bed during reperfusion were compared with the endocardial/epicardial blood flow ratios in the eight dogs with microsphere measurements who had TTC evi- dence of infarction, there was a good correlation between the two (Fig 6, B) 
Role of MCE in Determining Endocardial/Epicardial Flow Ratio
In models of myocardial ischemia not associated with infarction, unlike others,3334 we previously reported that MCE performed during intracoronary injection of microbubbles cannot be used to assess the endocardial/ epicardial blood flow ratio.13 Unlike the situation in myocardial infarction, the microvasculature is patent during ischemia. Since findings on MCE relate to flow/ volume relations rather than just flow alone, if reductions in endocardial flow are accompanied by concomitant reductions in the number of patent vessels,35 the flow/volume relation and, hence, the MCE parameters may remain unchanged. During ischemia, the number of patent vessels may decrease because of either lower distending pressure or higher myocardial pressure caused by ischemia.
In the present study, MCE was performed only in the presence of pharmacologically induced hyperemia, and the bubbles were injected into the LA or the RA. Since pharmacologically induced hyperemia increases blood flow by increasing intravascular volume,36 regions with greater intravascular blood volume during hyperemia had greater numbers of bubbles. Consequently, the good correlation between endocardial/epicardial peak video intensity ratio and endocardial/epicardial blood flow ratio probably occurred because of a higher intravascular blood volume (which translates into greater microvascular density) in the epicardial versus endocardial regions. The data were too "noisy" to generate time/intensity curves and examine myocardial transit rates of bubbles in the endocardium and epicardium as could be done with an intracoronary injections Taken together, the results of this and our previous study13 indicate that although MCE is not capable of defining the transmural distribution of flow in ischemia alone, in conjunction with pharmacologically induced hyperemia, it is capable of defining this distribution when microvascular injury is seen in association with subendocardial infarction.
Limitations of the Study
Pharmacological maneuvers used to achieve myocardial opacification from RA injection were not always successful. As in our previous experience," myocardial opacification was most likely (approximately 85% of the time) in the presence of intravenous dipyridamole. Although found to be safe in patients with coronary artery disease,37-39 even within 1 to 4 days after myocardial infarction,40 dipyridamole has not yet been approved by the Food and Drug Administration for use in the early phase of acute myocardial infarction in humans.
We used short-axis views of the heart, precluding assessment of the posterior bed because of attenuation resulting from left ventricular cavity opacification. Future studies using other imaging planes should enable evaluation of regional perfusion of the posterior bed. Because of subtle changes in video intensity in the myocardium, particularly from RA injection of contrast, we used image processing techniques such as alignment, Microsphere-Derived Endo/Epi Ratio FIG 6. Graphs. Panel A illustrates the relation between bloodflow within the risk area normalized to that in normally perfused myocardium (x axis) estimated by radiolabeled microsphere analysis and infarct size (% of risk area) determined by triphenyl tetrazolium chloride staining (y axis) in the 11 dogs in whom bloodflow was measured. Panel B illustrates the relation between the endocardial (endo)Iepicardial (epi) blood flow ratios estimated with radiolabeled microspheres (x axis) versus the ratios of background-subtracted peak video intensities from the endocardium and epicardium (y axis) in the eight dogs with infarction in whom blood flow measurements were made. LAD, left anterior descending coronary artery; MCE, myocardial contrast echocardiography.
These findings could have important implications in this era of interventional therapy. [24] [25] [26] Until recently, transpulmonary opacification of the myocardium had been difficult to achieve. We have, however, demonstrated successful myocardial opacification from RA injections of highly concentrated bubbles approximately 85% of the time using intravenous dipyridamole in dogs.11 Although technical problems such as image quality, signal-to-noise ratio, and attenuationinduced artifacts need to be overcome, the results of the present study set the stage for the use of MCE using intravenous contrast injections to determine the consequences of reperfusion therapy in humans.
